Aptamer Group

Aptamer Group, Ltd. is the developer of Optimer® binders to enable innovation in the life science industry.

The Optimer platform consists of three integrated discovery processes that together increase the potential target range of Optimer binders. These nucleic acid-based affinity ligands offer faster discovery, increased batch consistency and increased stability, to remove the need for freezers and longer shelf life than protein-based alternatives, to deliver a range of advantages to scientist